Literature DB >> 21474010

Vestibular neuritis.

John C Goddard1, Jose N Fayad.   

Abstract

The epidemiology, diagnostic features, differential diagnosis, and treatment of vestibular neuritis are reviewed. The authors present considerations for physical examination, imaging, and management in both the acute and chronic phases of this disease. The authors also present a dizziness questionnaire in the Appendix of this publication.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21474010     DOI: 10.1016/j.otc.2011.01.007

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  5 in total

1.  Clinical implication of ocular torsion in peripheral vestibulopathy.

Authors:  Jin Woong Choi; Seong Il Kang; Ji Hye Rhee; Byung Yoon Choi; Byeong Yoon Choi; Ji-Soo Kim; Ja-Won Koo
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-08       Impact factor: 2.503

2.  Monthly and seasonal variations in vestibular neuritis.

Authors:  Junhui Jeong; Yunbin Nam; Jangwon Oh; Hyun Seung Choi
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

3.  Three-Dimensional High-Resolution Temporal Bone Histopathology Identifies Areas of Vascular Vulnerability in the Inner Ear.

Authors:  Bela Büki; Antonia Mair; Jacob M Pogson; Nicholas S Andresen; Bryan K Ward
Journal:  Audiol Neurootol       Date:  2021-12-29       Impact factor: 2.213

Review 4.  Audiovestibular Disorders after COVID-19 Vaccine: Is There an Association?

Authors:  Davide Pisani; Federico Maria Gioacchini; Pasquale Viola; Alfonso Scarpa; Alessia Astorina; Massimo Re; Gianmarco Marcianò; Francesco Manti; Roberta Anzivino; Giuseppe Chiarella
Journal:  Audiol Res       Date:  2022-04-21

5.  Vestibular Neuritis With Minimal Canal Paresis: Characteristics and Clinical Implication.

Authors:  Hyun Ji Kim; Dae-Young Kim; Jun Ha Hwang; Kyu-Sung Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-09-27       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.